The use of heparin in a liquid form to measure ionized calcium (Ca") in plasma or whole blood can induce preanalytical errors by dilution and by changing the original C a + + value by binding or by re-equilibration with calcium in the anticoagulant solution.
SUMMARY. The use of heparin in a liquid form to measure ionized calcium (Ca") in plasma or whole blood can induce preanalytical errors by dilution and by changing the original C a + + value by binding or by re-equilibration with calcium in the anticoagulant solution.
To quantify these errors, C a + + was measured on serum pools under different sampling conditions. Incomplete syringe filling and specimen volume/syringe nominal volume ratio effects were tested. Syringes were rinsed with saline to yield pure dilution effects, with sodium heparinate to study binding and with calcium-titrated heparinate to evaluate 'calcium-distortion'. Detailed tables provide percentage error values for all sampling conditions. Dilution errors could reach -5% and binding was always important (-14 to -50%). Distortion was minimal around 1.25 mmol/L but could reach -4% for high and + 8% for low Ca+ + values. Errors increased when syringes were not filled to their nominal volume, especially with small-sized specimens.
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In specific clinical circumstances such as intensive care and surgery ionized calcium results are needed urgently.' Specimens have to be collected with anticoagulants, all of which bind calcium, the most commonly used being heparinate salts (sodium, lithium). The availability of calciumtitrated sodium (or lithium) heparinate minimizes the binding effect,24 but there is still a modification of the actual ionized calcium concentration when its value is different from that to which the heparinate has been titrated. Thus the use of an anticoagulant can induce three types of preanalytical error: (1) a dilution of the specimen ('solution-dilution') if the anticoagulant is used in an aqueous form; (2) 
MATERIAL AND METHODS
Three serum pools were prepared and ionized calcium concentrations adjusted to 0.74, 1.23 and 2.50 mmol/L with calcium chloride or EDTA.
To explore the effect of incomplete syringe filling, different sample volumes were drawn (0.5mL into 1 mL syringes, 1 and 2mL into 2.5mL syringes and 3,4 and 5mL into 5mL syringes). Measurements performed on dry syringes provided reference values.
Sera were sampled into syringes rinsed with three different types of solution: (1) isotonic saline which provided pure 'solution-dilution';
(2) sodium heparinate (Heparine Choay, France, 5000 IU/mL) which provided evaluation of calcium binding; and (3) calcium-titrated sodium heparinate (s-4500 Heparin, Radiometer, Denmark, 875 IU/mL) containing 1.25 mmol/L ionized calcium which provided a figure combining 'solution-dilution' and 'calcium-distortion'.
In preliminary work on 1 mL syringes: the tip of the syringe was filled exactly and carefully to introduce reproducible amounts of anticoagulant or saline solution. This was done by injecting the solution into the tip from a syringe with a needle. The volume thus introduced averaged 45 f 1 pL : 1.00 I -= = = -$ +:-:
Calcium binding by sodium heparinate and calcium-titrated heparinate was studied by adding increasing amounts of heparinate (1 5, 50 and lOOIU/mL) to plasma and whole blood specimens.
Ionized calcium and pH were measured by ion-selective electrodes (ICA 1, Radiometer, Copenhagen, Denmark) and total calcium by atomic absorption spectrophotometry (IL253, Instrumentation Laboratories). Serum specimens were tonometered (5% CO?) immediately prior to ionized calcium determination.
Statistical significance of the results was tested by the unpaired Student's t test. as determined by weight, which represented 220 IU of sodium heparinate and approximately 39 IU of calcium-titrated sodium heparinate. In an initial part of this work the same procedure was used to fill the tip of 2.5 and 5 mL syringes. The average volumes held were 125 and 220 pL, respectively. It appeared that the amount of heparinate thus introduced was too great. Subsequently syringes were 'rinsed' by carefully blowing out any residual liquid: this yielded a mean residual solution volume of 30 f 7pL as determined by weight. Since this result was of the same order of magnitude as that yielded by the 1 mL filling procedure, we chose to work with a uniformly introduced 45 pL volume to obtain comparable results between the different syringe types. Each solution or pool was sampled into 10 syringes and two measurements were performed on each syringe.
Direct addition of sodium-and calcium-titrated heparinates to plasma and whole blood yielded similar results. Figure 1 illustrates the data obtained with plasma. For a given concentration of sodium heparinate the per cent binding decreased with increasing concentrations of calcium: for 15 IU/mL it ranged from -2.2% to -1.4% for 0.75 and 1.75 mmol/L ionized calcium, respectively. It reached -6% and -1 1 % for 50 and 100 IU/mL, respectively. With calcium-titrated sodium heparinate 'calciumdistortion' was negligible for 1.25 mmol/L ionized calcium (less than 1 YO up to 100 IU/mL).
For 0.75 mmol/L ionized calcium, values were increased by less than + 3% up to 50 IU/mL but reached + 5% for 100 IU/mL. For 1.75 mmol/L ionized calcium values were decreased by less than -2% up to 50 IU/mL, but reached -4% for 100 IU/mL.
In the syringe studies for each type of serum the mean of 20 measurements was compared (% columns) with the dry syringe results which were taken as reference values. Table 1 shows the results obtained on a 1.25 mmol/L ionized calcium aqueous solution when syringe dead spaces were filled according to the initial protocol. In this series readings were erratic with a coefficient of variation above 1 YO. This was probably induced by the importance of calcium binding (35 to 60%) and the elevated amount of heparinate thus introduced (20& 250 IU/mL). Possible effects at the electrode membrane level, and sampling conditions irrelevant to clinical situations led us to abandon this type of testing. The rest of the work was performed introducing 45 pL of 'anticoagulant' solution independently of specimen volume or syringe nominal volume. Table 2 shows the results obtained under the latter conditions of syringe filling in the 1.25 mmol/L ionized calcium serum pool. The 'solution-dilution' error evidenced by saline addition was minimal with the 5mL syringe (less than 1%) in general, but significant (around 5%, P < 04005) on small specimens, as previously shown.' Binding by sodium heparinate was important in all cases, ranging from 10 to 40% (P c 0.0005). With calcium-titrated heparinate, modifications were clinically minimal (less than 0.7%) although statistically significant (P < 0.05) in some cases (for differences >0.2%). In this series, in contrast to the previous one, coefficients of variation were low, being below 0.5% with the exception of the results for sodium heparinate in 1 mL syringes. Table 3 and 4 show results obtained on the 0.75 and 2.50 mmol/L serum pools, respectively. Binding by sodium heparinate (data not shown) was above 10% in 5mL syringes and reached 50% in 1 mL syringes. When calcium-titrated sodium heparinate was used, results obtained in low as well as high ionized calcium pools showed changes ranging from less than 1 % to 5% according to sampling conditions. In this series coefficients of variation were low, below 0.5%.
Although pH values were uniform, in the range 7.32-7.35, pH 7.40 standardized values have also been reported: observed differences were similar to those shown by the actual values.
The raw calcium heparinate values were statistically different (P < 0.05) from the reference system (dry syringe). However, if one corrects these values for dilution, the persistent slight differences are not statistically significant.
DISCUSSION
In certain clinical circumstances, the results of an ionized calcium measurement are needed with very little Various sampling tubes (silicon-separator tubes,* tubes with coagulating devices) have been proposed to reduce blood clotting time and obtain serum with relatively short delay: analysing serum would ideally avoid any preanalytical error due to anticoagulation. Nevertheless analysis in urgent circumstances of an anticoagulated blood specimen is more convenient, if not a necessity. Analysis of whole blood has become widely used with modern analysers in intensive care; the use of plasma gives a better volume yield than serum, and use of whole blood allows an even smaller specimen, of importance in neonatal and paediatric practice. Last but not least, there is some dispute about the validity of results obtained on specimens collected in the containers yielding serum mentioned above, in that their use might induce some preanalytical causes of error 9~1 0 or directly damage the ion selective sensor.
The anticoagulant type (sodium heparinate or calcium-titrated sodium heparinate) as well as forms aqueous or dry state (induce different) preanalytical errors. To stress the importance of the errors which could occur, this study has been performed using sampling conditions representing extreme situations of blood collection.
'Solution-dilution' errors increased when the syringes were not filled to their nominal value.
They are clinically negligible in macro-sampling but might reach values as high as 5% when blood samples are of reduced volume as in paediatric practice.
It has been well established that, although heparinate salts bind calcium and modify the final result, it is acceptable to use sodium (or lithium) heparinate for clinical purposes as long as the final concentration does not exceed 15 IU/mL whole This is confirmed by the direct heparinate addition study reported here. However, one has to mention a recent reportI4 stating that as little as 2 IU/mL blood in plastic syringes and lOIU/mL blood in glass syringes provide satisfactory anticoagulation. The only commercially available sampling tubes fulfilling the 15 IU/mL requirement are 10 mL evacuated tubes containing 148 IU of heparinate, in which the amount of blood to be sampled is quite disproportionate when compared with the 200 or 300pL effectively necessary for the measurement. When the rest of the sample is not required for other measurements or if iterative determinations are necessary, this procedure is not ethically acceptable. On the other hand, the use of syringes rinsed with a heparinate solution is not a safe procedure, due to the variation in the amount of solution present in the syringe. This variability of the proportion of anticoagulant introduces a cause of preanalytical error. It can reach -50% in extreme conditions as mimicked by our experiments. It must be emphasized that even under the best sampling conditions ( 5 mL into a 5 m L syringe) the fact that a 'syringe rinse' introduces as much as 40 IU/mL heparinate, well above the recommended maximum limit of ISIU/mL, causes a 5% decrease in ionized calcium results. Attention must also be drawn to the fact that commercially available heparinized syringes designed for blood gas measurements usually contain from 50 (Arterial Sampler, Ciba Corning) to 120 IU/mL of heparinate (sodium or lithium), this being too high a n amount and rendering them inadequate for ionized calcium measurements. Recently, combined blood gaselectrolyte instruments have been marketed, raising the question of whether it is possible to run them with a sufficiently low anticoagulation to obtain valid results for ionized calcium without generating any problem with the blood gas part of the instrument.
The use of calcium-titrated heparinate (S-4500 heparin, Radiometer, Denmark-875 IU/mL; balanced lithium heparinate, Ciba Corning, Medfield, USA-200 IU/mL) minimizes these difficulties2.' but introduces a 'calcium-distortion' whether the anticoagulant is used in liquid or dry state." But in routine conditions there are some practical restrictions, the main one being financial. Another problem is that when patients are heparinized as in cardiac surgery with extracorporeal circulation, it is not safe to have around two types of heparinate ampoules: the calcium heparinate is not injectable and its concentration is much lower than in solutions used for patient heparinization. However, in our opinion the use of calcium-titrated heparinate is the best procedure to obtain valid results.
Nevertheless, in the interpretation of the result one has to keep in mind the causes of error demonstrated by our experiments: 'solution dilution' and 'calcium distortion' errors which are variable with the amount of specimen sampled and the difference between the actual ionized calcium value and 1.25 mmol/L (more precisely the value to which the heparinate was calcium-titrated). One can take into account the addition of the two types of errors by correcting 'calcium heparinate' results for the 'solution dilution' using the 'saline' percentage values and then calculating the percentage difference as compared to the reference value. This calculation increases the error for ionized calcium values equal to or higher than 1.25 mmol/L. Below this value the two types of error being of opposite signs, tend to cancel out. This 'calciumdistortion' is not clinically significant around the mean of the reference interval. For abnormally high ionized calcium values (2.50mmol/L) changes are relatively limited (7%) even in the worst sampling conditions. Changes appear to be more important for low values, and more sensitive to sample volumelsyringe nominal volume ratios. The direct heparinate addition experiments show that the induced modifications are clinically acceptable as long as the concentration of calcium titrated sodium heparinate does not exceed 50IU/mL. The most important error reported here was in a 0.5mL specimen with a final heparinate concentration (72 IU/mL) above this limit.
The 'solution-dilution' error can be cancelled by the use of calcium heparinate in a dry state. Several brands of capillary tubes of this type are commercially available and a similar critical study is in progress to evaluate the corresponding preanalytical errors they produce. Syringcs havc also been proposed (B-129-Heparinized Blood Sampler and QC-90. R a d i~m e t e r ) " . '~ but their price has prevented, for the moment, their widespread use. When using anticoagulants in a dry state, mixing immediately after sampling has to be very careful, using the magnetic stirrer in capillary tubes properly, rolling the syringes and inverting them several times.
That this study has been done with serum instead of whole blood or plasma and applying the corrections to whole blood implies an cxtrapolation is a valid criticism. Ncverthcless, the protocol adopted was the best which could bc achieved. Plasma was ruled out to avoid any intra-instrumental coagulation. Working on a sufficient bulk of whole blood would have needed a non-interfering anticoagulant which is not available. Sampling directly from a subject several specimens corresponding to the different experimental situations might have introduced errors due to differences between the differcnt samples. Tonometered serum from the same pool seemed to be the best way to reduce variations affecting the 'reference material' to be used.
CONCLUSIONS
To avoid preanalytical anticoagulant-induced errors in ionized calcium determinations the following recommendations should be taken into account.
The 
